Biochemical Pharmacology of the Sigma-1 Receptor

The sigma-1 receptor (S1R) is a 223 amino acid two transmembrane (TM) pass protein. It is a non-ATP-binding nonglycosylated ligand-regulated molecular chaperone of unknown three-dimensional structure. The S1R is resident to eukaryotic mitochondrial-associated endoplasmic reticulum and plasma membranes with broad functions that regulate cellular calcium homeostasis and reduce oxidative stress. Several multitasking functions of the S1R are underwritten by chaperone-mediated direct (and indirect) interactions with ion channels, G-protein coupled receptors and cell-signaling molecules involved in the regulation of cell growth. The S1R is a promising drug target for the treatment of several neurodegenerative diseases related to cellular stress. In vitro and in vivo functional and molecular characteristics of the S1R and its interactions with endogenous and synthetic small molecules have been discovered by the use of pharmacologic, biochemical, biophysical, and molecular biology approaches. The S1R exists in monomer, dimer, tetramer, hexamer/octamer, and higher oligomeric forms that may be important determinants in defining the pharmacology and mechanism(s) of action of the S1R. A canonical GXXXG in putative TM2 is important for S1R oligomerization. The ligand-binding regions of S1R have been identified and include portions of TM2 and the TM proximal regions of the C terminus. Some client protein chaperone functions and interactions with the cochaperone 78-kDa glucose-regulated protein (binding immunoglobulin protein) involve the C terminus. Based on its biochemical features and mechanisms of chaperone action the possibility that the S1R is a member of the small heat shock protein family is discussed.

[1]  T. Su,et al.  Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid , 2015, Proceedings of the National Academy of Sciences.

[2]  N. Natsvlishvili,et al.  Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria , 2015, BMC Biochemistry.

[3]  Deo R. Singh,et al.  The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. , 2015, The Biochemical journal.

[4]  H. Hara,et al.  Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage. , 2015, Experimental eye research.

[5]  J. Schnell,et al.  Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor , 2015, FEBS letters.

[6]  M. Sokabe,et al.  Sigma-1 (σ1) receptor deficiency reduces β-amyloid25–35-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B , 2015, Neuropharmacology.

[7]  T. Mavlyutov,et al.  Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS) , 2015, Journal of pharmacological sciences.

[8]  T. Su,et al.  Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders , 2014, Expert opinion on therapeutic targets.

[9]  J. Edwardson,et al.  A Direct Interaction between the Sigma-1 Receptor and the hERG Voltage-gated K+ Channel Revealed by Atomic Force Microscopy and Homogeneous Time-resolved Fluorescence (HTRF®)* , 2014, The Journal of Biological Chemistry.

[10]  Adrian Y. C. Wong,et al.  NMDA Receptors Are Upregulated and Trafficked to the Plasma Membrane after Sigma-1 Receptor Activation in the Rat Hippocampus , 2014, The Journal of Neuroscience.

[11]  B. Fox,et al.  The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands , 2014, The Journal of Biological Chemistry.

[12]  K. Klempnauer,et al.  The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding. , 2014, Biochemistry.

[13]  B. Kobilka,et al.  The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. , 2014, Current opinion in cell biology.

[14]  Andrew P. Stewart,et al.  The σ-1 Receptor Interacts Directly with GluN1 But Not GluN2A in the GluN1/GluN2A NMDA Receptor , 2013, The Journal of Neuroscience.

[15]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperone at the ER-Mitochondrion Interface Mediates the Mitochondrion-ER-Nucleus Signaling for Cellular Survival , 2013, PloS one.

[16]  S. Pricl,et al.  Structure of the σ1 receptor and its ligand binding site. , 2013, Journal of medicinal chemistry.

[17]  T. Mavlyutov,et al.  Lack of sigma-1 receptor exacerbates ALS progression in mice , 2013, Neuroscience.

[18]  J. Schnell,et al.  Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions* , 2013, The Journal of Biological Chemistry.

[19]  B. Fox,et al.  Improved expression and purification of sigma 1 receptor fused to maltose binding protein by alteration of linker sequence. , 2013, Protein expression and purification.

[20]  A. Hajipour,et al.  Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers. , 2013, Biochemistry.

[21]  S. Kourrich,et al.  Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine , 2013, Cell.

[22]  I. Katona,et al.  Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. , 2013, Human molecular genetics.

[23]  Teruo Hayashi,et al.  The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones* , 2012, The Journal of Biological Chemistry.

[24]  E. Sigel,et al.  Structure, Function, and Modulation of GABAA Receptors* , 2012, The Journal of Biological Chemistry.

[25]  Andrew P. Stewart,et al.  The Sigma-1 Receptor Binds to the Nav1.5 Voltage-gated Na+ Channel with 4-Fold Symmetry* , 2012, The Journal of Biological Chemistry.

[26]  X. Navarro,et al.  Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice , 2012, Neurotherapeutics.

[27]  Teruo Hayashi,et al.  Compromising σ-1 Receptors at the Endoplasmic Reticulum Render Cytotoxicity to Physiologically Relevant Concentrations of Dopamine in a Nuclear Factor-κB/Bcl-2-Dependent Mechanism: Potential Relevance to Parkinson's Disease , 2012, Journal of Pharmacology and Experimental Therapeutics.

[28]  Z. Janka,et al.  Association between a variant of the sigma-1 receptor gene and Alzheimer's disease , 2012, Neuroscience Letters.

[29]  J. Markley,et al.  The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. , 2012, European journal of pharmacology.

[30]  Jennifer A. Mirrielees,et al.  Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands , 2012, Brain Research.

[31]  P. Liu,et al.  Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase , 2012, Neuroscience.

[32]  Heather A. O'Neill,et al.  Small heat shock proteins and α-crystallins: dynamic proteins with flexible functions. , 2012, Trends in biochemical sciences.

[33]  A. Hajipour,et al.  The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. , 2012, Current pharmaceutical design.

[34]  F. Al-Mohanna,et al.  A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis , 2011, Annals of neurology.

[35]  A. Hajipour,et al.  Characterization of interactions of 4-nitrophenylpropyl-N-alkylamine with ς receptors. , 2011, Biochemistry.

[36]  R. Nickells,et al.  Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor , 2011, Molecular vision.

[37]  S. Buch,et al.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator. , 2010, Trends in pharmacological sciences.

[38]  P. Schofield,et al.  Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration–motor neuron disease , 2010, Annals of neurology.

[39]  K. Fuxe,et al.  Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine , 2010, Proceedings of the National Academy of Sciences.

[40]  T. Mavlyutov,et al.  The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study , 2010, Neuroscience.

[41]  Jean-Christophe Gelly,et al.  Detection and Architecture of Small Heat Shock Protein Monomers , 2010, PloS one.

[42]  M. Jackson,et al.  Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels. , 2010, Biophysical journal.

[43]  G. Pasternak,et al.  σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding , 2010, Molecular Pharmacology.

[44]  M. Kudo,et al.  SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression , 2010, Neuroscience Letters.

[45]  K. Becker,et al.  Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1·GTP pathway , 2009, Proceedings of the National Academy of Sciences.

[46]  P. Stewart,et al.  Structure and mechanism of protein stability sensors: chaperone activity of small heat shock proteins. , 2009, Biochemistry.

[47]  S. Pyne,et al.  The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. , 2009, European journal of pharmacology.

[48]  M. Jackson,et al.  The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.

[49]  A. Dibas,et al.  Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. , 2008, Investigative ophthalmology & visual science.

[50]  W. Bowen,et al.  Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation , 2008, Journal of Biological Chemistry.

[51]  V. Ganapathy,et al.  In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. , 2008, Investigative ophthalmology & visual science.

[52]  A. Hajipour,et al.  Juxtaposition of the Steroid Binding Domain-like I and II Regions Constitutes a Ligand Binding Site in the σ-1 Receptor* , 2008, Journal of Biological Chemistry.

[53]  I. Horváth,et al.  Membrane-associated stress proteins: more than simply chaperones. , 2008, Biochimica et biophysica acta.

[54]  A. Hajipour,et al.  Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. , 2008, Biochemistry.

[55]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[56]  E. Aydar,et al.  Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. , 2007, Cancer research.

[57]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[58]  A. Hajipour,et al.  Identification of Regions of the σ-1 Receptor Ligand Binding Site Using a Novel Photoprobe , 2007, Molecular Pharmacology.

[59]  T. Mavlyutov,et al.  Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells , 2007, Journal of molecular signaling.

[60]  A. Hajipour,et al.  Characterization of the cocaine binding site on the sigma-1 receptor. , 2007, Biochemistry.

[61]  A. Ruoho,et al.  Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. , 2007, Protein expression and purification.

[62]  H. Guizouarn,et al.  Cancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl– Channels* , 2007, Journal of Biological Chemistry.

[63]  S. Milstien,et al.  Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives* , 2007, Journal of Biological Chemistry.

[64]  F. Drago,et al.  Sigma receptor ligands protect human retinal cells against oxidative stress , 2006, Neuroreport.

[65]  Glennon Ra Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach. , 2005 .

[66]  T Sasaki,et al.  Function of sigma1 receptors in Parkinson's disease , 2005, Acta neurologica Scandinavica.

[67]  Teruo Hayashi,et al.  Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  K. Blumer,et al.  Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor* , 2003, Journal of Biological Chemistry.

[69]  G. Milligan Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. , 2003, Molecular pharmacology.

[70]  J. Carver,et al.  Small Heat‐shock Proteins and Clusterin: Intra‐ and Extracellular Molecular Chaperones with a Common Mechanism of Action and Function? , 2003, IUBMB life.

[71]  Teruo Hayashi,et al.  Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. , 2003, Current medicinal chemistry.

[72]  Teruo Hayashi,et al.  σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export , 2003, Journal of Pharmacology and Experimental Therapeutics.

[73]  J. Cuevas,et al.  Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. , 2002, Journal of neurophysiology.

[74]  Mark R. Wilson,et al.  Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin. , 2002, European journal of biochemistry.

[75]  Meyer B. Jackson,et al.  The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit , 2002, Neuron.

[76]  Andrew Coop,et al.  N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents. , 2002, Bioorganic & medicinal chemistry letters.

[77]  P. Casellas,et al.  Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. , 2001, Biochimica et biophysica acta.

[78]  Teruo Hayashi,et al.  Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Carver,et al.  Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. , 2000, Biochemistry.

[80]  H. Nakayama,et al.  (2R-trans)-2-butyl-5-heptylpyrrolidine as a potent sigma receptor ligand produced by Streptomyces longispororuber. , 2000, The Journal of antibiotics.

[81]  M. Wilson,et al.  Clusterin is a secreted mammalian chaperone. , 2000, Trends in biochemical sciences.

[82]  V. Ganapathy,et al.  Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. , 1999, The Journal of pharmacology and experimental therapeutics.

[83]  S. Okuyama,et al.  Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding , 1999, FEBS letters.

[84]  B. Kobilka,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[85]  H. Glossmann,et al.  High affinity of sigma1‐binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8–C7 isomerase , 1997, British journal of pharmacology.

[86]  H. Glossmann,et al.  Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. , 1996, Biochemistry.

[87]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[88]  E. Schmid,et al.  Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. , 1993, Molecular pharmacology.

[89]  A. Ruoho,et al.  (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[90]  W. Bowen,et al.  A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain , 1990, Brain Research.

[91]  C. Montigny,et al.  N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors , 1990 .

[92]  W. Bowen,et al.  Synthesis and evaluation of optically pure [3H]‐(+)‐pentazocine, a highly potent and selective radioligand for σ receptors , 1989 .

[93]  W. Bowen,et al.  Evidence for a multi-site model of the rat brain σ receptor , 1989 .

[94]  M. Kuhar,et al.  Cocaine binding at σ receptors , 1988 .

[95]  E. London,et al.  Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.

[96]  S. Mclean,et al.  Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain , 1988, Neuroscience.

[97]  S. Snyder,et al.  Structural determinants of sigma receptor affinity. , 1987, Molecular pharmacology.

[98]  Y. Itzhak [3H]PCP-3-OH and (+)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity. , 1987, European journal of pharmacology.

[99]  M. Sonders,et al.  1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[100]  S. Snyder,et al.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.

[101]  J. Ieni,et al.  Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality. , 1986, The Journal of pharmacology and experimental therapeutics.

[102]  S. Tam,et al.  Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[103]  S. Snyder,et al.  Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[104]  W R Martin,et al.  Pharmacology of opioids. , 1983, Pharmacological reviews.

[105]  S. Tam Naloxone-inaccessible sigma receptor in rat central nervous system. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[106]  D. B. Vaupel,et al.  Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog , 1983 .

[107]  T. Su Psychotomimetic opioid binding: specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1981, European journal of pharmacology.

[108]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[109]  B. Lucke-Wold,et al.  Role of sigma-1 receptors in neurodegenerative diseases. , 2015, Journal of pharmacological sciences.

[110]  K. Fukunaga,et al.  The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis. , 2015, Journal of pharmacological sciences.

[111]  吐尔洪 吐尔逊 SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression , 2010 .

[112]  E. Albuquerque,et al.  Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.

[113]  Teruo Hayashi,et al.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. , 2007, Cell.

[114]  A. Hajipour,et al.  Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. , 2007, Molecular pharmacology.

[115]  R. Glennon Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach. , 2005, Mini reviews in medicinal chemistry.

[116]  Teruo Hayashi,et al.  Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.

[117]  R. V. van Montfort,et al.  Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. , 2001, Advances in protein chemistry.

[118]  Obradovic,et al.  Predicting Binding Regions within Disordered Proteins. , 1999, Genome informatics. Workshop on Genome Informatics.

[119]  Obradovic,et al.  Predicting Protein Disorder for N-, C-, and Internal Regions. , 1999, Genome informatics. Workshop on Genome Informatics.

[120]  Kay Hofmann,et al.  Tmbase-A database of membrane spanning protein segments , 1993 .

[121]  G. Debonnel,et al.  N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. , 1990, European journal of pharmacology.

[122]  M. Kavanaugh,et al.  Solubilization and characterization of sigma-receptors from guinea pig brain membranes. , 1989, Journal of Neurochemistry.

[123]  W. Bowen,et al.  Evidence for a multi-site model of the rat brain sigma receptor. , 1989, European journal of pharmacology.

[124]  W. Bowen,et al.  Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors. , 1989, FEBS letters.

[125]  M. Kuhar,et al.  Cocaine binding at sigma receptors. , 1988, European journal of pharmacology.

[126]  L. Snell,et al.  Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands. , 1986, NIDA research monograph.

[127]  D. B. Vaupel,et al.  Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. , 1983, European journal of pharmacology.